# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3144824 | TCMDC-125382 | LUCIFERASE EXPRESSION CONTROL - IC90 | > | 9.42 | uM | ALA4483863 | uM | Plasmodium berghei | |||
2. | ALA3144824 | TCMDC-125382 | LUCIFERASE EXPRESSION CONTROL - IC50 | > | 9.42 | uM | ALA4483863 | uM | Plasmodium berghei | |||
3. | ALA3144824 | TCMDC-125382 | HEPG2TOX ASSAY - CC90 | = | 1.03 | uM | ALA4483864 | uM | Homo sapiens | |||
4. | ALA3144824 | TCMDC-125382 | HEPG2TOX ASSAY - CC50 | = | 1.03 | uM | ALA4483864 | uM | Homo sapiens | |||
5. | ALA3144824 | TCMDC-125382 | LUCIFERASE INFECTION ASSAY - IC90 | > | 9.42 | uM | ALA4483863 | uM | Plasmodium berghei | |||
6. | ALA3144824 | TCMDC-125382 | LUCIFERASE INFECTION ASSAY - IC50 | = | 1.03 | uM | ALA4483863 | uM | Plasmodium berghei | |||
7. | ALA3144824 | TCMDC-125382 | Inhibition | = | 5.45 | % | ALA3436043 | % | Plasmodium falciparum | |||
8. | ALA3144824 | TCMDC-125382 | Inhibition | = | 4.87 | % | ALA3436042 | % | Homo sapiens | |||
9. | ALA3144824 | TCMDC-125382 | Inhibition | = | 2.9 | % | ALA3436044 | % | Leishmania mexicana | |||
10. | ALA3144824 | TCMDC-125382 | XC50 | = | 1.006 | uM | ALA1054503 | 6.00 | nM | Plasmodium falciparum | ||
11. | ALA3144824 | TCMDC-125382 | Inhibition | = | 0 | % | ALA1054502 | % | Plasmodium falciparum | |||
12. | ALA3144824 | TCMDC-125382 | Inhibition | = | 0 | % | ALA1054504 | % | Homo sapiens | |||
13. | ALA3144824 | TCMDC-125382 | Inhibition | = | 61 | % | ALA1054501 | % | Plasmodium falciparum | |||
14. | ALA3144824 | TCMDC-125382 | IFI | = | 4.12 | % | ALA1054505 | % | ||||
15. | ALA3144824 | TCMDC-125382 | Inhibition | = | 88 | % | ALA1054500 | % | Plasmodium falciparum |